These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2283897)

  • 1. [Tumor necrosis factor: biologic significance, clinical importance and therapeutic usefulness].
    Bolufer P; Molina R
    Med Clin (Barc); 1990 Sep; 95(7):254-6. PubMed ID: 2283897
    [No Abstract]   [Full Text] [Related]  

  • 2. [The macrophage hormone interleukin 1 (IL-1) and the tumor necrosis factor. Biological and physiopathological significance].
    Bendtzen K
    Ugeskr Laeger; 1987 Aug; 149(33):2191-6. PubMed ID: 3502435
    [No Abstract]   [Full Text] [Related]  

  • 3. [Determination of serum levels of tumor necrosis factor in pediatric practice: usefulness and limitations].
    Pellegrino M; Minervini B; Ardito S; Checchia de Ambrosio C; Lotti F
    Pediatr Med Chir; 1995; 17(6):539-43. PubMed ID: 8668591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sarcoidosis, role of tumor necrosis factor inhibitors and other biologic agents, past, present, and future concepts.
    Sweiss NJ; Curran J; Baughman RP
    Clin Dermatol; 2007; 25(3):341-6. PubMed ID: 17560312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor-related apoptosis-inducing ligand pathway and its therapeutic implications.
    de Vries EG; Gietema JA; de Jong S
    Clin Cancer Res; 2006 Apr; 12(8):2390-3. PubMed ID: 16638843
    [No Abstract]   [Full Text] [Related]  

  • 6. [Tumor necrosis factor-alpha--biological and immunologic properties].
    Chciałowski A; Targowski T; Bajera I; Jahnz-Rózyk K
    Pol Merkur Lekarski; 1997 Jun; 2(12):392-5. PubMed ID: 9424334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor.
    Oettgen HF; Old LJ
    Important Adv Oncol; 1987; ():105-30. PubMed ID: 2841229
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical implications of the tumor necrosis factor family in benign and malignant hematologic disorders.
    Younes A; Aggarwall BB
    Cancer; 2003 Aug; 98(3):458-67. PubMed ID: 12879461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical probes using tumor necrosis factor in treatment of neoplastic diseases].
    Szczepanik A; Tabor J; Siedlar M
    Przegl Lek; 1994; 51(11):497-500. PubMed ID: 7871196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical significance of detection of serum tumor necrosis factor-alpha in children with cerebral cysticercosis].
    Wang MH; Li SH; Qiao ZX
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2001; 19(2):124. PubMed ID: 12572007
    [No Abstract]   [Full Text] [Related]  

  • 11. Emerging applications of the tumor necrosis factor family of ligands and receptors in cancer therapy.
    Younes A; Kadin ME
    J Clin Oncol; 2003 Sep; 21(18):3526-34. PubMed ID: 12972530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biology of tumor necrosis factor-alpha- implications for psoriasis.
    Schottelius AJ; Moldawer LL; Dinarello CA; Asadullah K; Sterry W; Edwards CK
    Exp Dermatol; 2004 Apr; 13(4):193-222. PubMed ID: 15086336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor alpha: a multifaceted peptide hormone.
    Rosenblum MG; Donato NJ
    Crit Rev Immunol; 1989; 9(1):21-44. PubMed ID: 2539946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of tumor necrosis factor alpha in asthma.
    Babu KS; Davies DE; Holgate ST
    Immunol Allergy Clin North Am; 2004 Nov; 24(4):583-97, v-vi. PubMed ID: 15474860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of association of severe preeclampsia with maternal and fetal mutant alleles for tumor necrosis factor alpha and lymphotoxin alpha genes and plasma tumor necrosis factor alpha levels.
    Livingston JC; Park V; Barton JR; Elfering S; Haddad B; Mabie WC; Quasney M; Sibai BM
    Am J Obstet Gynecol; 2001 May; 184(6):1273-7. PubMed ID: 11349201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The dual role of tumor necrosis factor (TNF) during a malarial attack].
    Brandts CH; Mordmüller BG; Lehman LG; Kremsner PG
    Sante; 1997; 7(4):271-4. PubMed ID: 9410454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of the expression of nuclear factor-kappa B, tumor necrosis factor receptor type 1 (TNFR 1) and c-Myc with the clinical course in the treatment of malignant astrocytomas with recombinant mutant human tumor necrosis factor-alpha (TNF-SAM2).
    Yamamoto M; Fukushima T; Hayashi S; Ikeda K; Tsugu H; Kimura H; Soma G; Tomonaga M
    Anticancer Res; 2000; 20(1C):611-8. PubMed ID: 10769704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNFerade Biologic: preclinical toxicology of a novel adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha gene.
    Rasmussen H; Rasmussen C; Lempicki M; Durham R; Brough D; King CR; Weichselbaum R
    Cancer Gene Ther; 2002 Nov; 9(11):951-7. PubMed ID: 12386834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor-alpha/nuclear transcription factor-kappaB signaling in periprosthetic osteolysis.
    Schwarz EM; Lu AP; Goater JJ; Benz EB; Kollias G; Rosier RN; Puzas JE; O'Keefe RJ
    J Orthop Res; 2000 May; 18(3):472-80. PubMed ID: 10937636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor, cancer and anticancer therapy.
    Mocellin S; Rossi CR; Pilati P; Nitti D
    Cytokine Growth Factor Rev; 2005 Feb; 16(1):35-53. PubMed ID: 15733831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.